WUS-14866-50897
2 vaccinations
1 coded response
23 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 088 / NJ
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- ULH-45644-73268
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Registered in v-safe
-
2022-06-25
Dose 1 — Pfizer-BioNTech
- 2022-06-25
- 2022-06-26
- 2022-06-27
-
2022-06-28
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Abnormal dreams, Nightmare — Feeling: Good · Be unable to do your normal daily activitiesFree text: Really vivid nightmaresMedDRA releases: 2024-11 · check-in free text available
- 2022-06-30
- 2022-07-01
- 2022-07-02
- 2022-07-09
-
2022-07-16
Dose 2 — Pfizer-BioNTech
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-30
- 2022-08-06
- 2022-08-13
- 2022-08-20
- 2022-08-27
- 2022-10-15
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Really vivid nightmares
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Abnormal dreams | · | · | ✓ |
| SRO | Nightmare | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release